JAN 30, 2016 6:38 AM PST

New System Effective At Testing Anticoagulants

WRITTEN BY: Kara Marker
Anticoagulant drugs thin the blood (I.E. “blood thinners”) to prevent dangerous clotting in the vessels. People take anticoagulants for a variety of reasons:
  • Prevent economy-class syndrome after knee or hip joint surgeries, a form of deep vein thrombosis named after the risk of developing this disorder after sitting on a plane too long
  • Coronary artery disease
  • Atrial fibrillation
Finding the right balance of medication is extremely important, because the blood needs to be able to clot to protect the body from excessive internal or external bleeding. A new type of anticoagulant, called novel oral anti-coagulants (NOACs), are some of the most effective blood thinners of the last decade. They can usually be used safely with other drugs, and patients taking NOACs do not have to change their diet.
 
The only problem that arises with using NOACs is understanding how their abilities affect different patients. Although they are highly effective, the lack of a technology to accurately determine their effect made it difficult for doctors to recommend an addition or switch with NOACs to their patients already taking anticoagulants.
 
A new system has alleviated this problem: the total thrombus-formation analysis system (T-TAS) developed by a Japanese company called Fujimori Kogyo Co., Ltd. T-TAS is uniquely able to test thrombus (blood clot) formation “under various blood flow conditions.” Plus, it only needs a small amount of whole blood for each test.
 
T-TAS

 
Killing two birds with one stone, researchers from Kumamoto University in Japan tested both the efficacy of the new system and the blood clotting risks of NOAC drugs. They looked at patients from three different cohorts, taking NOACs for various reasons. T-TAS proved to be extremely useful for determining the amount and variety of anticoagulants certain patients should take in certain situations (pre-surgery, post-surgery, etc.).
 
"With the help of T-TAS data, we were able to prevent future thrombotic and hemorrhagic complications,” said research leader Dr. Kaikita of Kumamoto University. The Kumamoto study was published in the International Journal of Cardiology.
 
Further use of T-TAS will help doctors provide patients with the perfect concoction of anticoagulants, making individualized medicine all the more accessible and easy.
 

Source: Kumamota University
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 16, 2020
Cardiology
A New Drug Candidate to Combat Cardiac Fibrosis
JUL 16, 2020
A New Drug Candidate to Combat Cardiac Fibrosis
Medicine is undoubtedly reaching a golden age, as researchers expand diagnostic and therapeutic tools like never before. ...
JUL 23, 2020
Cardiology
Protecting the Heart After a Heart Attack
JUL 23, 2020
Protecting the Heart After a Heart Attack
Cardiovascular disease accounts for thirty percent of mortalities around the world. These diseases start small and slowl ...
AUG 07, 2020
Cardiology
CT Method Can Find New Ways to Improve CPR
AUG 07, 2020
CT Method Can Find New Ways to Improve CPR
The time it takes for a person experiencing cardiac arrest to get help can make the difference between life and death.
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
OCT 15, 2020
Immunology
The Immune Cells Giving Menopausal Women Higher BPs
OCT 15, 2020
The Immune Cells Giving Menopausal Women Higher BPs
In general, men have higher blood pressures than women, giving them an increased risk of developing heart disease. After ...
NOV 10, 2020
Genetics & Genomics
Learning More About the Causes of Preeclampsia
NOV 10, 2020
Learning More About the Causes of Preeclampsia
Preeclampsia is a complication of pregnancy characterized by high blood pressure and it arises in anywhere from two to e ...
Loading Comments...